- Supported exchanges /
- WAR /
- PUR.WAR
Pure Biologics Spólka Akcyjna (PUR WAR) stock market data APIs
Pure Biologics S.A., a biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare neurological diseases. It is involved in the production, purification, analysis, and characterization of antibodies and aptamers; and design, development, and validation of assays, as well as conducts research on technology platforms for selecting active molecules. The company offers PureApta, a modular platform for in vitro selection of modified aptamers for therapeutic and diagnostic use. It also engages in the development of non-systemic therapies for use in treating patients suffering from neurological autoimmune disorders, including neuromyelitis optica and myasthenia gravis; and provides contract research for pharmaceutical and biotechnology companies. Pure Biologics S.A. was incorporated in 2010 and is headquartered in Wroclaw, Poland.
Pure Biologics Spólka Akcyjna Financial Data Overview
| 17.98 | |
| 18.26 | |
| - | |
| 18.26 | |
| 17.5 | |
| 5.01-33.2 | |
| 65 730 K | |
| 3 693 K | |
| 95 000 | |
| -1.4935 | |
| 1.413 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Pure Biologics Spólka Akcyjna Fundamental Data is available in our Financial Data APIs
- Net Revenue 95 000
- EBITDA -30 048 000
- Earnings Per Share -12.61
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Pure Biologics Spólka Akcyjna Earnings via APIs
- Latest Release 2024-03-31
- EPS/Forecast NaN
Get Pure Biologics Spólka Akcyjna End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
